Open Calls for Patient and Clinician Input
Listed are current opportunities for patient groups, clinician groups, drug plans, and cancer agencies to provide input or feedback on drugs being assessed within the reimbursement review process.
At CADTH, input is information, insight, or advice given to CADTH to contribute to a review. Feedback is a response to a prepared proposal, review report, or draft recommendation.
Therapeutic Area: Acute hepatic porphyria (AHP) in adults
Call For Patient Input: January 25, 2021
Patient Input Closed: March 19, 2021
Therapeutic Area: Osteoporosis, postmenopausal women
Call For Patient Input: January 4, 2021
Patient Input Closed: February 26, 2021
Therapeutic Area: Schizophrenia, adults
Call For Patient Input: December 24, 2020
Patient Input Closed: February 22, 2021
Therapeutic Area: Myelodysplastic syndromes-associated anemia
Call For Patient Input: December 23, 2020
Patient Input Closed: February 22, 2021
Therapeutic Area: chronic obstructive pulmonary disease (COPD)
Call For Patient Input: December 23, 2020
Patient Input Closed: February 22, 2021
Therapeutic Area: Diabetes mellitus
Call For Patient Input: December 22, 2020
Patient Input Closed: February 22, 2021
Therapeutic Area: Acute myeloid leukemia
Call For Patient Input: December 17, 2020
Patient Input Closed: February 12, 2021
Therapeutic Area: Cystic fibrosis, F508del CFTR mutation
Call For Patient Input: December 17, 2020
Patient Input Closed: February 12, 2021
Therapeutic Area: Acute myeloid leukaemia
Call For Patient Input: December 17, 2020
Patient Input Closed: February 12, 2021
Therapeutic Area: Classical Hodgkin lymphoma
Call For Patient Input: December 10, 2020
Patient Input Closed: February 5, 2021
Therapeutic Area: Acute myeloid leukemia
Call For Patient Input: December 3, 2020
Patient Input Closed: January 29, 2021
Therapeutic Area: Psoriatic Arthritis, Adults.
Call For Patient Input: November 27, 2020
Patient Input Closed: January 29, 2021